Nuala Pepper
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nuala Pepper has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Paul Lee
Department of Trauma and Orthopaedic Surgery, United Lincolnshire Teaching Hospitals NHS Trust, Lincoln LN2 5QY, UK
2 shared publications - Sedeek Mosaid
Department of Trauma and Orthopaedic Surgery, United Lincolnshire Hospitals NHS Trust, Lincoln, UK
2 shared publications - Ashok Marudanayagam
Orthopaedic Surgery Department, United Lincolnshire Hospitals NHS Trust, Lincoln LN2 5QY, UK
1 shared publication - Banah Khoshnaw
Chelsea and Westminster Hospital NHS Foundation Trust, London SW10 9NH, UK
1 shared publication - Charles Corbin
Department of Trauma and Orthopaedic Surgery, United Lincolnshire Teaching Hospitals NHS Trust, Lincoln LN2 5QY, UK
1 shared publication - Mohamed Elnemr
Orthopaedic Surgery Department, United Lincolnshire Hospitals NHS Trust, Lincoln LN2 5QY, UK
1 shared publication
Latest Publications
- Open Access
- 28 October 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (21) , 8381
Timing and Reported Indications for Revision After Anatomic Versus Reverse Total Shoulder Replacement: A National Joint Registry Study
Background/Objectives: Although reverse total shoulder replacement (RTSR) is now the predominant shoulder replacement procedure in England and Wales, RTSR and anatomic total shoulder replacement (anatomic TSR) serve mainly different indications and are seldom compared in terms of when and why they are revised. We aimed to describe the timing and reported indications for the first revision of each construct and quantify the between-construct comparison that the National Joint Registry (NJR) describes only qualitatively. Methods: We conducted a secondary analysis of published aggregate data from the NJR’s 22nd Annual Report for elective primary anatomic TSR (n = 21,180) and RTSR (n = 39,408) performed in England and Wales between 2012 and 2024. We used NJR’s published Kaplan–Meier and prosthesis-time incidence rate (PTIR) estimates to derive the unadjusted between-construct difference (anatomic TSR minus RTSR) in cumulative revision at each time point, with approximate 95% confidence intervals (CIs), and rate ratios for each reported revision indication. Results: In these unadjusted estimates, the between-construct difference was −0.66 percentage points at 1 year (95% CI [−0.85, −0.47]), close to 0 at 3 years, and 3.52 percentage points at 12 years (95% CI [2.19, 4.85]). Revision for infection (rate ratio, 2.43), periprosthetic fracture (1.75) and instability (1.26) was more common after RTSR, whereas cuff insufficiency was markedly less frequent (PTIR 0.01 vs. 0.34 per 100 prosthesis years). Conclusions: The constructs differ in revision timing and reported indications. Because they are used for different indications in patients of different ages, these unadjusted data are descriptive and cannot establish comparative superiority or guide construct selection alone.
- 28 October 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (21) , 8381
Open AccessTiming and Reported Indications for Revision After Anatomic Versus Reverse Total Shoulder Replacement: A National Joint Registry Study
Background/Objectives: Although reverse total shoulder replacement (RTSR) is now the predominant shoulder replacement procedure in England and Wales, RTSR and anatomic total shoulder replacement (anatomic TSR) serve mainly different indications and are seldom compared in terms of when and why they are revised. We aimed to describe the timing and reported indications for the first revision of each construct and quantify the between-construct comparison that the National Joint Registry (NJR) describes only qualitatively. Methods: We conducted a secondary analysis of published aggregate data from the NJR’s 22nd Annual Report for elective primary anatomic TSR (n = 21,180) and RTSR (n = 39,408) performed in England and Wales between 2012 and 2024. We used NJR’s published Kaplan–Meier and prosthesis-time incidence rate (PTIR) estimates to derive the unadjusted between-construct difference (anatomic TSR minus RTSR) in cumulative revision at each time point, with approximate 95% confidence intervals (CIs), and rate ratios for each reported revision indication. Results: In these unadjusted estimates, the between-construct difference was −0.66 percentage points at 1 year (95% CI [−0.85, −0.47]), close to 0 at 3 years, and 3.52 percentage points at 12 years (95% CI [2.19, 4.85]). Revision for infection (rate ratio, 2.43), periprosthetic fracture (1.75) and instability (1.26) was more common after RTSR, whereas cuff insufficiency was markedly less frequent (PTIR 0.01 vs. 0.34 per 100 prosthesis years). Conclusions: The constructs differ in revision timing and reported indications. Because they are used for different indications in patients of different ages, these unadjusted data are descriptive and cannot establish comparative superiority or guide construct selection alone.
- Open Access
- 19 September 2026
- Published by MDPI AG in Bioengineering
- Vol. 13 (9) , 1088
3D-Printed and Biofabricated Scaffolds for Osteoporotic Bone Defect Repair: Mechanical Adaptation, Redox Control, Senescence Modulation and Osteoimmunomodulation
Fragility fracture and osteoporotic bone loss represent an increasing global burden in ageing populations: the Global Burden of Disease Study 2021 estimated 172.79 million new fractures, 453.31 million prevalent cases, and 25.18 million years lived with disability in 2021, yet the resulting defects are still managed with grafts and scaffolds validated in healthy bone. Osteoporotic bone is not merely rarefied normal bone but a distinct regenerative microenvironment, in which we propose that oxidative stress, cellular senescence, and loss of osteogenesis-coupled type-H vasculature act as a mutually reinforcing triad, superimposed on an adipogenically biassed progenitor pool, blunted osteocyte mechanotransduction and immunosenescence. Additive manufacturing and biofabrication permit patient-specific geometry and spatial and temporal programming of mechanical and biological cues. This review appraises four interdependent design axes—mechanical adaptation through functionally graded, trabecular-mimetic architectures; redox regulation; senescence modulation; and osteoimmunomodulation coupled to vascularisation—distinguishing study type, disease specificity and author-proposed hypotheses. The most direct clinical signal is mechanical: in a retrospective cohort of 163 lumbar interbody fusion levels, printed porous titanium was associated with subsidence in 5.5% of levels versus 24.4% for solid titanium. By contrast, almost all redox, senescence and immunomodulatory scaffold evidence remains preclinical: osteoporosis-specific evidence relies heavily on ovariectomised rodents, and much of the rest comes from non-osteoporotic models. Within the searches described, we identified no completed clinical evaluation with reported results of a multifunctional scaffold in an osteoporosis-defined cohort. As the authors’ proposed conceptual framework rather than an established result, we suggest that these axes be engaged sequentially rather than additively, and that timing, dose and spatial distribution may matter more than the number of bioactivities.
- 19 September 2026
- Published by MDPI AG in Bioengineering
- Vol. 13 (9) , 1088
Open Access3D-Printed and Biofabricated Scaffolds for Osteoporotic Bone Defect Repair: Mechanical Adaptation, Redox Control, Senescence Modulation and Osteoimmunomodulation
Fragility fracture and osteoporotic bone loss represent an increasing global burden in ageing populations: the Global Burden of Disease Study 2021 estimated 172.79 million new fractures, 453.31 million prevalent cases, and 25.18 million years lived with disability in 2021, yet the resulting defects are still managed with grafts and scaffolds validated in healthy bone. Osteoporotic bone is not merely rarefied normal bone but a distinct regenerative microenvironment, in which we propose that oxidative stress, cellular senescence, and loss of osteogenesis-coupled type-H vasculature act as a mutually reinforcing triad, superimposed on an adipogenically biassed progenitor pool, blunted osteocyte mechanotransduction and immunosenescence. Additive manufacturing and biofabrication permit patient-specific geometry and spatial and temporal programming of mechanical and biological cues. This review appraises four interdependent design axes—mechanical adaptation through functionally graded, trabecular-mimetic architectures; redox regulation; senescence modulation; and osteoimmunomodulation coupled to vascularisation—distinguishing study type, disease specificity and author-proposed hypotheses. The most direct clinical signal is mechanical: in a retrospective cohort of 163 lumbar interbody fusion levels, printed porous titanium was associated with subsidence in 5.5% of levels versus 24.4% for solid titanium. By contrast, almost all redox, senescence and immunomodulatory scaffold evidence remains preclinical: osteoporosis-specific evidence relies heavily on ovariectomised rodents, and much of the rest comes from non-osteoporotic models. Within the searches described, we identified no completed clinical evaluation with reported results of a multifunctional scaffold in an osteoporosis-defined cohort. As the authors’ proposed conceptual framework rather than an established result, we suggest that these axes be engaged sequentially rather than additively, and that timing, dose and spatial distribution may matter more than the number of bioactivities.